156 related articles for article (PubMed ID: 2360247)
21. Cyclosporine: immunology, toxicity and pharmacology in experimental animals.
Thomson AW; Whiting PH; Simpson JG
Agents Actions; 1984 Oct; 15(3-4):306-27. PubMed ID: 6395677
[TBL] [Abstract][Full Text] [Related]
22. Morphologic studies of intestinal allograft rejection. Immunosuppression with cyclosporine.
Cohen Z; Nordgren S; Lossing A; Cullen J; Craddock G; Langer B
Dis Colon Rectum; 1984 Apr; 27(4):228-34. PubMed ID: 6714029
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporine A vs cyclosporine A metabolites: comparisons of in vivo and in vitro immunosuppressive and toxic effects.
Kim PC; Cohen Z; Wong PY; Craig M; Cullen J; Levy GA
Transplant Proc; 1990 Dec; 22(6):2487-90. PubMed ID: 2264120
[No Abstract] [Full Text] [Related]
24. Histology of rat small bowel transplants: cyclosporine A ameliorates features of rejection including apoptosis and ganglion cell reduction.
Collins MH; Yang R; Liu Q; Cnaan A; Pescovitz MD; Grosfeld JL
J Pediatr Surg; 1997 Apr; 32(4):555-9. PubMed ID: 9126753
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine and experimental skin allografts: long-term survival in rats treated with low maintenance doses.
Towpik E; Kupiec-Weglinski JW; Tyler DS; Araujo JL; Schneider TM; Araneda D; Murphy GM; Tilney NL
Plast Reconstr Surg; 1986 Feb; 77(2):268-76. PubMed ID: 3511482
[TBL] [Abstract][Full Text] [Related]
26. The role of ultraviolet B-irradiated leukocyte transfusions and cyclosporine in intestinal transplantation.
Xiao F; Foster PF; Sankary HN; Templeton AC; Kociss K; Williams JW
Transplantation; 1992 Jul; 54(1):32-7. PubMed ID: 1631941
[TBL] [Abstract][Full Text] [Related]
27. Failure of cyclosporine to prevent small bowel allograft rejection in pigs.
Pritchard TJ; Madara JL; Tapper D; Wilmore DW; Kirkman RL
J Surg Res; 1985 Jun; 38(6):553-8. PubMed ID: 4010265
[TBL] [Abstract][Full Text] [Related]
28. Improved immunosuppression with aerosolized cyclosporine in experimental pulmonary transplantation.
Keenan RJ; Duncan AJ; Yousem SA; Zenati M; Schaper M; Dowling RD; Alarie Y; Burckart GJ; Griffith BP
Transplantation; 1992 Jan; 53(1):20-5. PubMed ID: 1733067
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
Wang J; Xu R; Jin R; Chen Z; Fidler JM
Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
[TBL] [Abstract][Full Text] [Related]
30. Small bowel transplantation in the rat. Effect of pretransplant blood transfusions and cyclosporine on host survival.
Martinelli GP; Knight RK; Kaplan S; Racelis D; Dikman SH; Schanzer H
Transplantation; 1988 Jun; 45(6):1021-6. PubMed ID: 3260047
[TBL] [Abstract][Full Text] [Related]
31. A comparison of heterotopic and orthotopic intestinal transplantation in rats.
Grant D; Zhong R; Hurlbut D; Garcia B; Chen HF; Lamont D; Wang PZ; Stiller C; Duff J
Transplantation; 1991 May; 51(5):948-54. PubMed ID: 2031277
[TBL] [Abstract][Full Text] [Related]
32. Reconstruction of the intestinal lymphatic drainage after small bowel transplantation.
Kellersman R; Zhong R; Kiyochi H; Garcia B; Grant DR
Transplantation; 2000 Jan; 69(1):10-6. PubMed ID: 10653372
[TBL] [Abstract][Full Text] [Related]
33. Evidence that LS-2616 (linomide) causes acute rejection of rat allografts protected by cyclosporine but not of long-term surviving allografts.
Wanders A; Vogt P; Karlsson-Parra A; Wonigkeit K; Gerdin B; Tufveson G
Transplantation; 1991 Aug; 52(2):234-8. PubMed ID: 1871795
[TBL] [Abstract][Full Text] [Related]
34. Structural shifts in the intestinal microbiota of rats treated with cyclosporine A after orthotropic liver transplantation.
Jia J; Tian X; Jiang J; Ren Z; Lu H; He N; Xie H; Zhou L; Zheng S
Front Med; 2019 Aug; 13(4):451-460. PubMed ID: 31020543
[TBL] [Abstract][Full Text] [Related]
35. Evidence that cyclosporine prevents rejection and recurrent diabetes in pancreatic transplants in the BB rat.
Dugoni WE; Bartlett ST
Transplantation; 1990 May; 49(5):845-8. PubMed ID: 2336700
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the in vivo immunosuppressive activity of the major cyclosporine metabolite by leukemia allograft rejection.
Freed BM; Bennett JA; Rosano TG; Brooks CA; Cramer SM; Lempert N
Transplantation; 1992 Feb; 53(2):456-60. PubMed ID: 1738941
[TBL] [Abstract][Full Text] [Related]
37. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin.
Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL
J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporine and skin allografts for the treatment of thermal injury. I. Extensive graft survival with low-level long-term administration and prolongation in a rat burn model.
Hewitt CW; Black KS; Aguinaldo AM; Achauer BM; Howard EB
Transplantation; 1988 Jan; 45(1):8-12. PubMed ID: 3276067
[TBL] [Abstract][Full Text] [Related]
40. Influence of the hepatic drug-metabolizing enzyme-inducer phenobarbitone on cyclosporine nephrotoxicity and hepatotoxicity in renal-allografted rats.
Duncan JI; Heys SD; Thomson AW; Simpson JG; Whiting PH
Transplantation; 1988 Apr; 45(4):693-7. PubMed ID: 3282350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
